We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$290M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$259M
3
JNJ icon
Johnson & Johnson
JNJ
+$245M
4
JPM icon
JPMorgan Chase
JPM
+$133M
5
MSFT icon
Microsoft
MSFT
+$111M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$175M
2
KSU
Kansas City Southern
KSU
+$105M
3
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$97M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$50.8M
5
BDX icon
Becton Dickinson
BDX
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UUP icon
4176
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
– –
-59,855
Closed -$1.5M
VCEL icon
4177
Vericel Corp
VCEL
$2.27B
– –
-3,631
Closed -$202K
VERI icon
4178
Veritone
VERI
$131M
– –
-15,690
Closed -$376K
VICI icon
4179
CALL
VICI Properties
VICI
$28.7B
– –
-16,500
Closed -$2K
VIPS icon
4180
Vipshop
VIPS
$7.48B
– –
-32,410
Closed -$968K
VIR icon
4181
Vir Biotechnology
VIR
$1.5B
– –
-3,975
Closed -$204K
VNRX icon
4182
VolitionRx Ltd
VNRX
$9.38M
– –
-1,556
Closed -$118K
VTRS icon
4183
PUT
Viatris
VTRS
$18.8B
– –
-16,900
Closed -$30K
VIVO
4184
VivoPower PLC
VIVO
$121M
– –
-3,151
Closed -$318K
YARW
4185
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
– –
-15
Closed -$95K
WES icon
4186
PUT
Western Midstream Partners
WES
$19.5B
– –
-17,000
Closed -$6K
WLKP icon
4187
Westlake Chemical Partners
WLKP
$762M
– –
-15,943
Closed -$383K
WM icon
4188
CALL
Waste Management
WM
$90.5B
– –
-15,600
Closed -$257K
ZTR
4189
Virtus Total Return Fund
ZTR
$337M
– –
-13,595
Closed -$125K
BODI icon
4190
CALL
The Beachbody Company
BODI
$74.6M
– –
-242
Closed -$4K
TRAW icon
4191
Traws Pharma
TRAW
$8.34M
– –
-103
Closed -$38K
UCB
4192
United Community Banks
UCB
$4.25B
– –
-9,322
Closed -$318K
NPKI
4193
NPK International
NPKI
$1.16B
– –
-47,676
Closed -$150K
QQQH
4194
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$383M
– –
-17,916
Closed -$961K
PAVMZ
4195
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
– –
-389,353
Closed -$1.1M
AKTS
4196
DELISTED
Akoustis Technologies Inc
AKTS
– –
-24,722
Closed -$330K
JWSM.U
4197
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
– –
-50,000
Closed -$508K
GTHX
4198
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-13,500
Closed -$62K
CVIIU
4199
DELISTED
Churchill Capital Corp VII Units
CVIIU
– –
-50,000
Closed -$499K
MORF
4200
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-6,004
Closed -$380K
166 167
168
169 170

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.